Riley Moore, in Afton, WY - Marriage & Family Therapist

Riley Moore, is a Marriage & Family Therapist based in Afton, Wyoming. Riley Moore is licensed to practice in Wyoming (license number PMFT-310) and her current practice location is 389 Adams St, Afton, Wyoming. She can be reached at her office (for appointments etc.) via phone at (307) 885-9883.

NPI number for Riley Moore is 1982486965 and her current mailing address is Po Box 376, Afton, Wyoming. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1982486965.

Contact Information

	Riley Moore,
	389 Adams St, Afton, WY 83110-5056
	(307) 885-9883
	(307) 885-5206

Healthcare Provider's Profile

Full Name	Riley Moore
Gender	Female
Speciality	Marriage & Family Therapist
Location	389 Adams St, Afton, Wyoming
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1982486965
Provider Enumeration Date: 10/16/2023
Last Update Date: 10/16/2023

Medical Identifiers

Medical identifiers for Riley Moore such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1982486965	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	PMFT-310 (Wyoming)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Riley Moore is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Riley Moore, Po Box 376, Afton, WY 83110-0376 Ph: (307) 885-9883	Riley Moore, 389 Adams St, Afton, WY 83110-5056 Ph: (307) 885-9883

News Archive

Preventing tumours from making new blood vessels can also prevent spread of cancer

Patients with advanced prostate cancer are often treated with hormones, but when the tumours start growing again they have more and different blood vessels, reveals a thesis from the Sahlgrenska Academy, at the University of Gothenburg, Sweden. This discovery paves the way for new treatments for hormone-resistant prostate cancer.

Low PSA score after radiation can predict prostate cancer return

A consortium of prostate cancer experts have discovered, through a clinical investigation, that prostate cancer patients who have a lower prostate specific antigen (PSA) score after radiation therapy to treat their cancer are less likely to have their prostate cancer return or spread to other parts of their body than patients with a higher PSA score.

Scientists find epigenetic landscape map for tissue differentiation

Having charted the occurrence of a common chemical change that takes place while stem cells decide their fates and progress from precursor to progeny, a Johns Hopkins-led team of scientists has produced the first-ever epigenetic landscape map for tissue differentiation.The details of this collaborative study between Johns Hopkins, Stanford and Harvard appear August 15 in the early online publication of Nature.

Benzodiazepines and related drugs frequently used before and after diagnosis of Alzheimer's disease

Benzodiazepines and related drugs are initiated frequently in persons with Alzheimer's disease already before the diagnosis, and their use becomes even more common after the diagnosis, shows a recent study from the University of Eastern Finland.

Riley Moore, - Couples Therapy in Afton, WY